
    
      Randomized prospective study conducted on 30 patients of both genders ranging in age from 18
      to 60 years, with neck and shoulder girdle Myofascial Pain Syndrome (MFS), with a duration of
      ≥ 4 months and pain intensity ≥ 4.

      Trigger point injection of 1 mL 0.25% bupivacaine at each point, once a week for 8 weeks (T1
      to T8).

      Group 1: kinesiotherapy once a week for 8 weeks Group 2: not submitted to kinesiotherapy
      Evaluation of pain intensity on the first assessment (T0) and after 1, 2, 3, 4, 5, 6, 7, 8,
      and 9 weeks
    
  